Develop and execute targeted engagement strategies for key accounts and treatment centers in the Central US region.
Lead regional business planning and collaborate with cross-functional teams to drive commercial launch readiness.
Serve as primary point of contact for stakeholders, ensuring alignment with corporate goals and market access strategies.
Since 2009, REGENXBIO has pioneered gene therapy, advancing a pipeline of treatments for rare and retinal diseases. Their growing, mission-driven team collaborates to develop transformative therapies for patients in need.
Lead strategic engagement with payers, PBMs, and GPO accounts to secure patient access.
Develop market access strategies and negotiate contracts, including value-based models.
Build and oversee payer account teams while collaborating across functions.
REGENXBIO is a gene therapy company pioneering treatments for rare and retinal diseases. The company fosters a collaborative, patient-focused culture with a talented team working to make a meaningful difference for patients and their families.
Design and lead the U.S. field reimbursement team for the launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
Partner with payer strategy, hub vendor, and cross-functional teams to ensure compliant patient access and reimbursement.
Own field reimbursement SOPs, budget, and team performance while capturing insights to shape market access strategy.
Capricor Therapeutics is a biotechnology company advancing transformative cell and exosome-based therapies for rare diseases. It is a publicly traded, mission-driven organization with a collaborative culture focused on scientific rigor and execution.
Sets trade channel strategy, serves as executive relationship lead for National Retail and strategic partners, and manages day-to-day trade and distribution operations.
Leads trade activation, contracting, and compliance to ensure product access, inventory management, and measurable account growth.
Builds and directs the trade function, collaborating cross-functionally to optimize channel economics and launch readiness.
ARS Pharmaceuticals is a fast-growing, innovative company dedicated to transforming severe allergic reaction treatment with the first FDA-approved needle-free epinephrine. The culture is collaborative, entrepreneurial, and inclusive, driven by a mission to make a meaningful impact.
Lead commercial operations and analytics for the U.S. launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
Build and oversee commercial data ecosystem, analytics, forecasting, and field operations.
Establish scalable processes, governance, and cross-functional partnerships to drive launch readiness.
Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. The company is publicly traded and fosters a collaborative, mission-driven culture focused on innovation and patient impact.
Develop and maintain senior payer relationships across a ten-state Northeast territory.
Lead account strategy for 16 accounts including Highmark, Independence, Point32Health, and UPMC.
Coordinate cross-functionally to resolve access barriers and support rare disease launches.
BridgeBio is a biopharmaceutical company using a 'moneyball for biotech' model to advance early-stage research and develop rare disease treatments. It values curiosity, experimentation, and boundary-pushing, fostering a collaborative culture with respected industry minds.
Execute logistics demand planning and forecast consolidation across Life Sciences and Diagnostics business units.
Coordinate inventory movement, distribution capacity, and import/export compliance in a regulated environment.
Maintain planning master data, build dashboards, and support scenario modeling for disruptions.
Beacon Biosignals is transforming precision medicine for the brain, offering at-home EEG platforms for clinical development and diagnostics. The company is growing with robust remote practices and has office hubs in Boston, New York, and Paris.
Serve as regional reimbursement expert, educating providers on access pathways and addressing barriers in commercial and government payer environments.
Coordinate family access and support, ensuring compliant education and seamless coordination among providers, pharmacies, and internal teams.
Act as a senior cross-functional partner, generating field insights and contributing to access strategy while mentoring colleagues.
BridgeBio pioneered a 'moneyball for biotech' approach, pooling early-stage research to reduce risk and unleash innovation for rare diseases. They value curiosity and experimentation, with a culture that defies convention and empowers problem-solvers.
Manage end-to-end clinical supply chain planning, execution, and oversight for cardiomyopathy programs.
Oversee shipping and logistics operations, including carrier management, import/export compliance, and cold-chain coordination.
Partner cross-functionally to align supply timelines and ensure compliant drug supply.
Atrium is a biopharmaceutical company pioneering delivery of RNA therapeutics to the heart to treat cardiomyopathies. It is a small, growing company with a fast-paced, autonomous culture.
Lead and execute access and reimbursement strategy aligned with BridgeBio objectives.
Manage, coach, and develop a team of Field Reimbursement Managers.
Serve as a senior subject matter expert on payer coverage, prior authorization, and reimbursement pathways.
BridgeBio is a biopharma company that develops life-changing medicines for rare diseases and unmet medical needs, using a 'moneyball for biotech' model to pool early-stage research. They value curiosity, experimentation, and ethical AI use, and foster a collaborative, family-focused culture.
Support clinical trial recruitment and site outreach, coordinating feedback with clinical teams.
Establish scientific relationships with KOLs in the Duchenne community and refine KOL mapping.
Gather scientific insights and attend medical conferences as a Medical Affairs representative.
REGENXBIO is a biotechnology company focused on developing novel AAV gene therapies for patients with rare diseases. The company has a collaborative culture driven by core values of trust, accountability, perseverance, and innovation.
Lead clinical supply chain activities including labeling, packaging, global distribution, inventory management, and IP reconciliation.
Develop and maintain supply plans aligned with clinical enrollment, dosing, regulatory timelines, and study milestones.
Provide operational oversight of contract organizations for packaging, labeling, and distribution.
Entrada is a clinical-stage biopharmaceutical company developing genetic medicines for neuromuscular and inherited retinal diseases. They are a tight-knit team of experts in therapeutic development and rare diseases, dedicated to improving patients' lives.
Build and lead commercial data, advanced analytics, and forecasting capabilities to support launch readiness.
Develop patient-based forecasts and decision-support models to guide commercial strategy.
Translate complex data into actionable insights and KPIs for senior executives and operating teams.
REGENXBIO is a gene therapy company advancing a pipeline of treatments for rare and retinal diseases. The culture is purpose-driven and collaborative, with a focus on making a meaningful difference for patients and their families.